Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Stopping imipramine reduced the woman's hair loss.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Non-ablative Er:YAG laser effectively treats hair loss with high patient satisfaction and no side effects.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

The model and estimator can predict drug exposure in kidney transplant patients well.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Using platelet-rich plasma with microneedling works better for acne scars than microneedling with water.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.